Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18053
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThabet, M. A.en
dc.contributor.authorChalla, A.en
dc.contributor.authorChan, J. C.en
dc.contributor.authorPandak, W. M.en
dc.contributor.authorHeuman, D. M.en
dc.contributor.authorVlahcevic, Z. R.en
dc.date.accessioned2015-11-24T18:50:19Z-
dc.date.available2015-11-24T18:50:19Z-
dc.identifier.issn0085-2538-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18053-
dc.rightsDefault Licence-
dc.subjectAnimalsen
dc.subjectCholesterol/*metabolismen
dc.subjectCholesterol 7-alpha-Hydroxylase/metabolismen
dc.subjectCircadian Rhythmen
dc.subjectFemaleen
dc.subjectHydroxymethylglutaryl CoA Reductases/metabolismen
dc.subjectLiver/*metabolism/ultrastructureen
dc.subjectNephrotic Syndrome/chemically induced/enzymology/*metabolismen
dc.subjectPuromycinen
dc.subjectRatsen
dc.subjectRats, Sprague-Dawleyen
dc.subjectSterol Esterase/metabolismen
dc.subjectSterol O-Acyltransferase/metabolismen
dc.titleStudies of alteration of hepatic cholesterol metabolism in puromycin-induced nephrotic syndrome in ratsen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/8258956-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1993-
heal.abstractHypercholesterolemia frequently accompanies the nephrotic syndrome, but the mechanism responsible for elevation of plasma cholesterol is poorly understood. Specifically, the contribution of abnormal hepatic cholesterol metabolism to elevated concentrations of serum cholesterol has never been studied in depth. The objective of the present study was to define the alteration of hepatic cholesterol metabolism in puromycin induced nephrotic syndrome in rats. Studies involved measurements of specific activities of four enzymes participating in the maintenance of hepatic cholesterol metabolism: HMG-CoA-reductase, the rate limiting enzyme of cholesterol synthesis; cholesterol 7 alpha-hydroxylase, the rate limiting enzyme in bile acid synthesis; acyl CoA: cholesterol acyltransferase, the enzyme responsible for esterification of cholesterol; and cholesterol ester hydrolase (CEH), an enzyme which hydrolyzes cholesterol. Multiple injections of puromycin resulted in a production of nephrotic syndrome with massive proteinuria, hypoalbuminemia, hypercholesterolemia, ascites and edema. HMG-CoA-reductase (nmol/hr/mg protein) and cholesterol 7 alpha-hydroxylase activities (nmol/hr/mg protein) in rats with nephrotic syndrome were not statistically significant as compared to control rats (4.0 +/- 0.7 and 2.0 +/- 0.6 vs. 3.3 +/- 0.4 and 1.6 +/- 0.2), respectively. Our results also demonstrate, for the first time, that the normal diurnal rhythm in HMG-CoA reductase activity is no longer present in the nephrotic animals. The activities in the nephrotics in the day was 4.0 nmol/hr/mg and at night, 3.9 nmol/hr/day, compared to the control values of 3.3 nmol/hr/mg in the day and 6.9 nmol/hr/mg at night. ACAT activities were 428 +/- 78 versus 302 +/- 64 pmol/min/mg/protein (P = NS).(ABSTRACT TRUNCATED AT 250 WORDS)en
heal.journalNameKidney Internationalen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons